We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy

News   Aug 13, 2015

 
Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy
 
 
 

RELATED ARTICLES

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Retina Restoration Could Return Vision to Our Canine Friends

News

A stem cell-based approach is being developed to treat blindness in dogs.

READ MORE

150-year-old Drug Could Improve Cancer Radiation Therapy

News

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE